methotrexate has been researched along with Carcinoma, Intraepithelial in 18 studies
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 5 (27.78) | 18.7374 |
| 1990's | 10 (55.56) | 18.2507 |
| 2000's | 1 (5.56) | 29.6817 |
| 2010's | 2 (11.11) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Ahmadi, N; Amini, E; Bazargani, ST; Cai, J; Clifford, TG; Daneshmand, S; Djaladat, H; Hugen, CM; Miranda, G; Sherrod, AE | 1 |
| Cote, RJ; Esrig, D; Groshen, S; Hall, C; Klotz, L; Lerner, SP; Raghavan, D; Shi, SR; Skinner, DG; Stadler, WM; Stein, JP; Steinberg, G; Wood, D | 1 |
| Kosnikov, AG; Maksimov, SIa; Semiglazov, VF; Semiglazov, VV | 1 |
| Soloway, MS | 1 |
| Hofmann, W; Langkopf, B | 1 |
| Brockerhoff, P; Casper, F; Hofmann, M; Mahlke, M | 1 |
| Gertenbach, U; Hohenfellner, R; Huber, C; Meyenburg, W; Stöckle, M; Thüroff, JW; Voges, G; Wellek, S | 1 |
| Abi-Aad, AS; deKernion, JB; Figlin, R; Stenzl, A | 1 |
| Amano, T; Hisazumi, H; Koshida, K; Kunimi, K; Morishita, H; Naito, K | 1 |
| Guy, RL; Husband, JE; Knee, G; MacVicar, AD; Powles, TJ; Sloane, JP; Vinnicombe, SJ | 1 |
| Senécal, JL; Uthman, I; Vázquez-Abad, D | 1 |
| Ng, RS | 1 |
| Fowble, B; Freedman, G; Goldstein, LJ; Hanlon, AL; Hoffman, JP; Patchefsky, A; Sigurdson, ER | 1 |
| Herr, HW | 1 |
| Ang, J; Habs, M; Schmähl, D | 1 |
| Grau, C; Overgaard, J | 1 |
| Meyer, JS | 1 |
| Ringrose, CA | 1 |
5 trial(s) available for methotrexate and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Phase III study of molecularly targeted adjuvant therapy in locally advanced urothelial cancer of the bladder based on p53 status.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Female; Follow-Up Studies; Humans; Immunoenzyme Techniques; Male; Methotrexate; Molecular Targeted Therapy; Prospective Studies; Survival Rate; Treatment Outcome; Tumor Suppressor Protein p53; Urinary Bladder Neoplasms; Vinblastine | 2011 |
[The modern organ- and function-sparing surgical treatment in oncology].
Topics: Adenocarcinoma; Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Breast Neoplasms; Carcinoma in Situ; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Electrosurgery; Endometrial Neoplasms; Estrogen Receptor Modulators; Female; Fluorouracil; Humans; Hysterectomy; Lymph Node Excision; Lymphatic Metastasis; Mastectomy; Methotrexate; Middle Aged; Neoplasm Metastasis; Neoplasm Recurrence, Local; Ovarian Neoplasms; Postoperative Care; Progestins; Prognosis; Prospective Studies; Radiotherapy Dosage; Risk Factors; Survival Analysis; Time Factors; Uterine Cervical Neoplasms | 2003 |
Systemic therapy for superficial bladder cancer.
Topics: Animals; Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Clinical Trials as Topic; Cyclophosphamide; FANFT; Female; Fluorouracil; Humans; Male; Methotrexate; Mice; Neoplasm Recurrence, Local; Pyridoxine; Urinary Bladder Neoplasms; Vitamin A | 1984 |
[The role of M-VAC polychemotherapy in the treatment of advanced urothelial carcinoma of the bladder].
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Doxorubicin; Epirubicin; Female; Humans; Lymphatic Metastasis; Male; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Palliative Care; Remission Induction; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Primary breast cancer: mammographic changes after neoadjuvant chemotherapy, with pathologic correlation.
Topics: Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Female; Humans; Mammography; Methotrexate; Middle Aged; Mitomycin; Mitoxantrone; Tamoxifen | 1996 |
13 other study(ies) available for methotrexate and Carcinoma, Intraepithelial
| Article | Year |
|---|---|
Long term oncologic outcome in patients with bladder cancer after radical cystectomy: Impact of carcinoma in situ in the era of neoadjuvant chemotherapy.
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Chemotherapy, Adjuvant; Cisplatin; Cystectomy; Deoxycytidine; Disease-Free Survival; Doxorubicin; Female; Follow-Up Studies; Gemcitabine; Humans; Male; Methotrexate; Middle Aged; Neoadjuvant Therapy; Neoplasm Grading; Neoplasm Staging; Neoplasms, Multiple Primary; Survival Rate; Time Factors; Urinary Bladder Neoplasms; Vinblastine | 2019 |
[Possibilities and value of intracavitary and systemic chemotherapy of bladder cancer].
Topics: Antineoplastic Agents; Carcinoma in Situ; Cisplatin; Cyclophosphamide; Doxorubicin; Drug Therapy, Combination; Fluorouracil; Humans; Methotrexate; Mitomycin; Mitomycins; Teniposide; Thiotepa; Urinary Bladder; Urinary Bladder Neoplasms | 1982 |
[Persistent granulocytosis and hyperuricemia after a single G-CSF injection (Filgrastim) in treatment of chemotherapy-induced myelosuppression in metastatic breast carcinoma].
Topics: Aged; Antineoplastic Combined Chemotherapy Protocols; Bone Marrow; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Chemotherapy, Adjuvant; Combined Modality Therapy; Cyclophosphamide; Dose-Response Relationship, Drug; Drug Administration Schedule; Female; Filgrastim; Fluorouracil; Granulocyte Colony-Stimulating Factor; Granulocytes; Humans; Injections, Subcutaneous; Leukocyte Count; Methotrexate; Radiotherapy, Adjuvant; Recombinant Proteins; Uric Acid | 1995 |
Pathologic response and long term results of preoperative M-VAC regimen in regionally advanced transitional cell carcinoma of the bladder.
Topics: Adult; Aged; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carcinoma, Transitional Cell; Cisplatin; Doxorubicin; Drug Administration Schedule; Female; Humans; Male; Methotrexate; Middle Aged; Neoplasm Staging; Retrospective Studies; Urinary Bladder Neoplasms; Vinblastine | 1993 |
Percutaneous mitomycin C perfusion of bilateral ureteral carcinoma in situ.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cisplatin; Doxorubicin; Humans; Male; Methotrexate; Middle Aged; Mitomycin; Nephrostomy, Percutaneous; Time Factors; Ureteral Neoplasms; Vinblastine | 1993 |
Distinctive features of idiopathic inflammatory myopathies in French Canadians.
Topics: Adult; Anti-Inflammatory Agents; Antibodies, Antinuclear; Antirheumatic Agents; Arthritis, Rheumatoid; Breast Neoplasms; Canada; Carcinoma; Carcinoma in Situ; Carcinoma, Squamous Cell; Creatine Kinase; Esophageal Neoplasms; Female; Follow-Up Studies; Histidine-tRNA Ligase; Humans; Longitudinal Studies; Lymphoma, T-Cell; Male; Methotrexate; Middle Aged; Mixed Connective Tissue Disease; Nuclear Envelope; Polymyositis; Prednisone; Pulmonary Fibrosis; Retrospective Studies; Scleroderma, Systemic; Skin Neoplasms; Survival Analysis | 1996 |
The reproductive imperative: a case report highlighting the possibility of using chemotherapy to conserve the testis in patients with testis cancer.
Topics: Adult; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Attitude to Health; Bleomycin; Carboplatin; Carcinoma in Situ; Humans; Male; Methotrexate; Neoplasms, Second Primary; Testicular Neoplasms; Vincristine | 1997 |
The presence of proliferative breast disease with atypia does not significantly influence outcome in early-stage invasive breast cancer treated with conservative surgery and radiation.
Topics: Adult; Aged; Aged, 80 and over; Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Carcinoma, Ductal, Breast; Carcinoma, Lobular; Chemotherapy, Adjuvant; Cisplatin; Combined Modality Therapy; Cyclophosphamide; Doxorubicin; Estrogen Replacement Therapy; Female; Fluorouracil; Follow-Up Studies; Humans; Hyperplasia; Methotrexate; Middle Aged; Neoplasm Recurrence, Local; Neoplasm Staging; Precancerous Conditions; Radiotherapy Dosage; Survival Analysis | 1998 |
The natural history of a T1 bladder cancer: life-long tumour diathesis.
Topics: Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Cisplatin; Combined Modality Therapy; Cystectomy; Disease Susceptibility; Doxorubicin; Humans; Male; Methotrexate; Middle Aged; Urinary Bladder Neoplasms; Vinblastine | 1999 |
Chemotherapy studies in autochthonous rat tumors. Forestomach and bladder cancer.
Topics: Animals; Antineoplastic Agents; Bleomycin; Carcinoma in Situ; Doxorubicin; Drug Combinations; Female; Fluorouracil; Methotrexate; Neoplasms, Experimental; Papilloma; Rats; Stomach Neoplasms; Urinary Bladder Neoplasms | 1977 |
Effect of etoposide, carmustine, vincristine, 5-fluorouracil, or methotrexate on radiobiologically oxic and hypoxic cells in a C3H mouse mammary carcinoma in situ.
Topics: Animals; Antineoplastic Agents; Antineoplastic Combined Chemotherapy Protocols; Carcinoma in Situ; Carmustine; Cell Division; Cell Hypoxia; Combined Modality Therapy; Etoposide; Female; Fluorouracil; Male; Mammary Neoplasms, Experimental; Methotrexate; Mice; Mice, Inbred C3H; Vincristine | 1992 |
Cell kinetics in selection and stratification of patients for adjuvant therapy of breast carcinoma.
Topics: Antineoplastic Combined Chemotherapy Protocols; Breast; Breast Neoplasms; Carcinoma in Situ; Cell Cycle; DNA, Neoplasm; Epithelium; Evaluation Studies as Topic; Female; Flow Cytometry; Fluorouracil; Humans; Melphalan; Methotrexate; Neoplasm Invasiveness; Neoplasm Staging; Prognosis; Receptors, Estrogen; Receptors, Progesterone; Thymidine; Tritium | 1986 |
Carcinoma in situ of the cervix after amethopterin therapy.
Topics: Adult; Carcinoma in Situ; Female; Humans; Methotrexate; Psoriasis; Uterine Cervical Neoplasms; Vaginal Smears | 1974 |